Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 283,815 | 151,471 | 63,787 | -29,041 | -118,345 |
| Depreciation Amortization | 144,871 | 73,016 | 274,955 | 205,029 | 136,245 |
| Income taxes - deferred | -30,109 | -17,889 | -196,644 | -258,708 | -213,256 |
| Accounts receivable | -258,357 | 27,205 | -110,237 | 7,976 | 24,207 |
| Other Working Capital | -132,701 | 20,429 | -132,329 | 503,530 | 396,733 |
| Other Operating Activity | 398,741 | -8,733 | 688,168 | -2,430 | -36,332 |
| Operating Cash Flow | $406,260 | $245,499 | $587,700 | $426,356 | $189,252 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -140,145 | -73,460 | -322,832 | -244,626 | -163,816 |
| Purchase Of Investment | -575,354 | -253,742 | -812,734 | -476,851 | -460,615 |
| Sale Of Investment | 304,300 | 120,699 | 1,746,198 | 933,333 | 768,427 |
| Other Investing Activity | -32,774 | -6,317 | -617,125 | 22,836 | -11,632 |
| Investing Cash Flow | $-443,973 | $-212,820 | $-6,493 | $234,692 | $132,364 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 285,333 | 21,064 | 74,164 | 59,151 | 43,704 |
| Common Stock Repurchased | -195,274 | -113,172 | -692,752 | -609,180 | -491,212 |
| Other Financing Activity | 0 | 0 | -149,692 | -149,692 | -149,692 |
| Financing Cash Flow | $90,059 | $-92,108 | $-768,280 | $-699,721 | $-597,200 |
| Beginning Cash Position | 208,130 | 208,130 | 395,203 | 395,203 | 395,203 |
| End Cash Position | 260,476 | 148,701 | 208,130 | 356,530 | 119,619 |
| Net Cash Flow | $52,346 | $-59,429 | $-187,073 | $-38,673 | $-275,584 |
| Free Cash Flow | |||||
| Operating Cash Flow | 406,260 | 245,499 | 587,700 | 426,356 | 189,252 |
| Capital Expenditure | -140,145 | -73,460 | -322,832 | -244,626 | -163,816 |
| Free Cash Flow | 266,115 | 172,039 | 264,868 | 181,730 | 25,436 |